Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 264 articles: HTML format

Single Articles

November 2021
1. KATZ DH, Tahir UA, Bick AG, Pampana A, et al
   Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights into Cardiovascular Disease.
   Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.055117.
   PubMed     Abstract available
   
   
   
2. SREEJIT G, Nooti SK, Jaggers RM, Athmanathan B, et al
   Retention of the NLRP3 Inflammasome-primed Neutrophils in the Bone Marrow is Essential for Myocardial Infarction-induced Granulopoiesis.
   Circulation. 2021 Nov 17. doi: 10.1161/CIRCULATIONAHA.121.056019.
   PubMed     Abstract available
   
   
   
3. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
   Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
   Circulation. 2021;144:1656-1658.
   PubMed    
   
   
   
4. LAI Y, Zhuang X, Liao X
   Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
   Circulation. 2021;144:e307.
   PubMed    
   
   
   
5. HAKALA JO, Raitakari OT, Rovio SP
   Response by Hakala et al to Letter Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
   Circulation. 2021;144:e308-e309.
   PubMed    
   
   
   
6. WYCKOFF MH, Singletary EM, Soar J, Olasveengen TM, et al
   2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and T
   Circulation. 2021 Nov 11:CIR0000000000001017. doi: 10.1161/CIR.0000000000001017.
   PubMed     Abstract available
   
   
   
7. ZAHA VG, Hayek SS, Alexander KM, Beckie TM, et al
   Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association.
   Circulation. 2021 Nov 10:CIR0000000000001032. doi: 10.1161/CIR.0000000000001032.
   PubMed     Abstract available
   
   
   
8. 
   Correction to: Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
   Circulation. 2021;144:e306.
   PubMed    
   
   
   
9. TONG DC, Bloom JE, Quinn S, Nasis A, et al
   Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.
   Circulation. 2021;144:1584-1586.
   PubMed    
   
   
   
10. LADDU D, Ma J, Kaar J, Ozemek C, et al
    Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 4:CIR0000000000001026. doi: 10.1161/CIR.0000000000001026.
    PubMed     Abstract available
    
    
    
11. MICHOS ED, Udell JA
    Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death.
    Circulation. 2021;144:1485-1488.
    PubMed    
    
    
    
12. CHUANG YT, Ueng KC, Tsai CF
    Grouped Beating After Acute Inferior Myocardial Infarction.
    Circulation. 2021;144:1518-1520.
    PubMed    
    
    
    
13. LICHTENSTEIN AH, Appel LJ, Vadiveloo M, Hu FB, et al
    2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 2:CIR0000000000001031. doi: 10.1161/CIR.0000000000001031.
    PubMed     Abstract available
    
    
    
14. COWIE MR, Deanfield J
    Cardiovascular Medicine at a Crossroads in the United Kingdom.
    Circulation. 2021;144:1457-1458.
    PubMed    
    
    
    
15. MCNALLY EM, Elkind MSV, Benjamin IJ, Chung MK, et al
    Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.
    Circulation. 2021 Nov 1:CIR0000000000001027. doi: 10.1161/CIR.0000000000001027.
    PubMed     Abstract available
    
    
    October 2021
16. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available
    
    
    
17. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    PubMed     Abstract available
    
    
    
18. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
    Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
    Circulation. 2021;144:1449-1451.
    PubMed    
    
    
    
19. BRAILLON A
    Letter by Braillon Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
    Circulation. 2021;144:e274.
    PubMed    
    
    
    
20. PENG AW, Dardari ZA, Blaha MJ
    Response by Peng et al to Letter Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
    Circulation. 2021;144:e275-e276.
    PubMed    
    
    
    
21. NEELAND IJ, McGuire DK, Sattar N
    Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?
    Circulation. 2021;144:1359-1361.
    PubMed    
    
    
    
22. SANCHEZ-LOPEZ A, Espinos-Estevez C, Gonzalez-Gomez C, Gonzalo P, et al
    Cardiovascular Progerin Suppression and lamin A Restoration Rescues Hutchinson-Gilford Progeria Syndrome.
    Circulation. 2021 Oct 25. doi: 10.1161/CIRCULATIONAHA.121.055313.
    PubMed     Abstract available
    
    
    
23. KRIS-ETHERTON PM, Petersen KS, Despres JP, Anderson CAM, et al
    Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2021 Oct 25:CIR0000000000001018. doi: 10.1161/CIR.0000000000001018.
    PubMed     Abstract available
    
    
    
24. ALE-AGHA N, Jakobs P, Goy C, Zurek M, et al
    Mitochondrial Telomerase Reverse Transcriptase Protects from Myocardial Ischemia/reperfusion Injury by Improving Complex I Composition and Function.
    Circulation. 2021 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051923.
    PubMed     Abstract available
    
    
    
25. 
    Correction to: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
    Circulation. 2021;144:e273.
    PubMed    
    
    
    
26. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    PubMed     Abstract available
    
    
    
27. GANGAVELLI A, Morris AA
    Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?
    Circulation. 2021;144:1280-1283.
    PubMed    
    
    
    
28. JACOBS AK, Ali MJ, Best PJ, Bieniarz MC, et al
    Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.
    Circulation. 2021 Oct 13:CIR0000000000001025. doi: 10.1161/CIR.0000000000001025.
    PubMed     Abstract available
    
    
    
29. LEE LY, Oldham WM, He H, Wang R, et al
    Interferon-gamma Impairs Human Coronary Artery Endothelial Glucose Metabolism via Tryptophan Catabolism and Activates Fatty Acid Oxidation.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.053960.
    PubMed     Abstract available
    
    
    
30. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
    Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
    PubMed     Abstract available
    
    
    
31. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed     Abstract available
    
    
    
32. RUEL M, Fischbein M
    Introduction to the 2021 Cardiovascular Surgery Themed Issue of Circulation.
    Circulation. 2021;144:1087.
    PubMed    
    
    
    
33. CHOI S, Lee K, Park SM
    Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
    Circulation. 2021 Oct 4. doi: 10.1161/CIRCULATIONAHA.121.054967.
    PubMed    
    
    
    September 2021
34. 
    Correction to: Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.
    Circulation. 2021;144:e213.
    PubMed    
    
    
    
35. ALLARD-RATICK MP, McCarthy CP, Jang IK
    Letter by Allard-Ratick et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e206.
    PubMed    
    
    
    
36. MATTA A, Elbaz M, Roncalli J
    Letter by Matta et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e204.
    PubMed    
    
    
    
37. HAMILTON GW, Tan S, Layland J
    Letter by Hamilton et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e207-e208.
    PubMed    
    
    
    
38. REYNOLDS HR, Kwong RY, Maehara A, Smilowitz NR, et al
    Response by Reynolds et al to Letters Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e209-e210.
    PubMed    
    
    
    
39. NGUYEN TH, Ong GJ, Horowitz JD
    Letter by Nguyen et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e205.
    PubMed    
    
    
    
40. BERGSTROM G, Persson M, Adiels M, Bjornson E, et al
    Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population.
    Circulation. 2021;144:916-929.
    PubMed     Abstract available
    
    
    
41. GENTILE F, Castiglione V, De Caterina R
    Coronary Artery Anomalies.
    Circulation. 2021;144:983-996.
    PubMed     Abstract available
    
    
    
42. KUEHN BM
    Increasing Burnout Could Have Dire Effects on the Cardiovascular Workforce After the Pandemic.
    Circulation. 2021;144:997-999.
    PubMed    
    
    
    
43. MERID B, Robles MC, Nallamothu BK
    Digital Redlining and Cardiovascular Innovation.
    Circulation. 2021;144:913-915.
    PubMed    
    
    
    
44. FILIPPATOS G, Agarwal R, Bakris G, Anker S, et al
    Response by Filippatos et al to Letter Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes".
    Circulation. 2021;144:e202-e203.
    PubMed    
    
    
    
45. LOTHER A, Bode C, Hein L
    Letter by Lother et al Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes".
    Circulation. 2021;144:e201.
    PubMed    
    
    
    
46. SATTLER S
    Single-Cell Immunology in Cardiovascular Medicine: Do We Know Yet What We Do Not Know?
    Circulation. 2021;144:843-844.
    PubMed    
    
    
    
47. TIAN M, Wang X, Sun H, Feng W, et al
    No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
    Circulation. 2021 Sep 13. doi: 10.1161/CIRCULATIONAHA.121.055525.
    PubMed    
    
    
    
48. REYNOLDS HR, Shaw LJ, Min JK, Page CB, et al
    Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Circulation. 2021 Sep 9. doi: 10.1161/CIRCULATIONAHA.120.049755.
    PubMed     Abstract available
    
    
    August 2021
49. HASSELBALCH RB, Bundgaard H, Iversen KK
    Response by Hasselbalch et al to Letter Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e169-e170.
    PubMed    
    
    
    
50. SANDOVAL Y, Jaffe AS
    Letter by Sandoval and Jaffe Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e168.
    PubMed    
    
    
    
51. HWANG P, Schulz R, Kavsak P
    Letter by Hwang et al Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e166-e167.
    PubMed    
    
    
    
52. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
    Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057042.
    PubMed     Abstract available
    
    
    
53. LOPES RD, Higano CS, Slovin SF, Nelson AJ, et al
    Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.056810.
    PubMed     Abstract available
    
    
    
54. SMITS PC, Frigoli E, Tijssen J, Juni P, et al
    Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
    Circulation. 2021 Aug 29. doi: 10.1161/CIRCULATIONAHA.121.056680.
    PubMed     Abstract available
    
    
    
55. MARSTON NA, Giugliano RP, Park JG, Ruzza A, et al
    Cardiovascular Benefit of Lowering LDL Cholesterol Below 40 mg/dl.
    Circulation. 2021 Aug 27. doi: 10.1161/CIRCULATIONAHA.121.056536.
    PubMed    
    
    
    
56. 
    Correction to: Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
    Circulation. 2021;144:e164.
    PubMed    
    
    
    
57. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.
    PubMed    
    
    
    
58. DANG TA, Kessler T, Wobst J, Wierer M, et al
    Identification of a Functional PDE5A Variant at the Chromosome 4q27 Coronary Artery Disease Locus in an Extended Myocardial Infarction Family.
    Circulation. 2021;144:662-665.
    PubMed    
    
    
    
59. MATSKEPLISHVILI S, Kontsevaya A
    Cardiovascular Health, Disease, and Care in Russia.
    Circulation. 2021;144:586-588.
    PubMed    
    
    
    
60. MEWTON N, Roubille F, Bresson D, Prieur C, et al
    Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
    Circulation. 2021 Aug 23. doi: 10.1161/CIRCULATIONAHA.121.056177.
    PubMed    
    
    
    
61. CHOW SL, Sasson C, Benjamin IJ, Califf RM, et al
    Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2021 Aug 19:CIR0000000000001007. doi: 10.1161/CIR.0000000000001007.
    PubMed     Abstract available
    
    
    
62. 
    Correction to: Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
    Circulation. 2021;144:e150.
    PubMed    
    
    
    July 2021
63. JOYNT MADDOX KE, Gilstrap LG
    Is Rising Cardiovascular Spending a Good News or Bad News Story?
    Circulation. 2021;144:283-285.
    PubMed    
    
    
    
64. PIRILLO A, Catapano AL
    Omega-3 for Cardiovascular Diseases: Where Do We Stand After REDUCE-IT and STRENGTH?
    Circulation. 2021;144:183-185.
    PubMed    
    
    
    
65. CHAITMAN BR, Reynolds HR, Maron DJ, Hochman JS, et al
    Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e14-e15.
    PubMed    
    
    
    
66. CORREIA LCL, Viana MS
    Letter by Correia and Viana Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e12-e13.
    PubMed    
    
    
    
67. 
    Retraction and Replacement of: Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Circulation. 2021;144:e36.
    PubMed    
    
    
    
68. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.
    PubMed    
    
    
    
69. PATEL AP, Wang M, Kartoun U, Ng K, et al
    Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.052430.
    PubMed    
    
    
    
70. STREED CG JR, Beach LB, Caceres BA, Dowshen NL, et al
    Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jul 8:CIR0000000000001003. doi: 10.1161/CIR.0000000000001003.
    PubMed     Abstract available
    
    
    
71. ZHANG Q, Burrage MK, Lukaschuk E, Shanmuganathan M, et al
    Towards Replacing Late Gadolinium Enhancement with Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Circulation. 2021 Jul 7. doi: 10.1161/CIRCULATIONAHA.121.054432.
    PubMed     Abstract available
    
    
    
72. LI Y, Lu G
    Letter by Li and Lu Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e6-e7.
    PubMed    
    
    
    
73. HENDREN NS, de Lemos JA, Grodin JL
    Response by Hendren et al to Letter Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e8-e9.
    PubMed    
    
    
    
74. NELSON AJ, Pagidipati NJ, Aroda VR, Cavender MA, et al
    Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
    Circulation. 2021;144:74-84.
    PubMed     Abstract available
    
    
    
75. SCHUNK SJ, Triem S, Schmit D, Zewinger S, et al
    Interleukin-1alpha (IL-1alpha) is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease.
    Circulation. 2021 Jul 1. doi: 10.1161/CIRCULATIONAHA.121.053547.
    PubMed     Abstract available
    
    
    June 2021
76. WERESKI R, Kimenai DM, Taggart C, Doudesis D, et al
    Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.
    Circulation. 2021 Jun 25. doi: 10.1161/CIRCULATIONAHA.121.054302.
    PubMed     Abstract available
    
    
    
77. 
    Correction to: A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).
    Circulation. 2021;143:e1118.
    PubMed    
    
    
    
78. 
    Correction to: Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2021;143:e1116.
    PubMed    
    
    
    
79. DROBNI ZD, Mayrhofer T, Hoffmann U, Neilan TG, et al
    Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1033-e1034.
    PubMed    
    
    
    
80. SARAYANI A, Jugl S, Winterstein AG
    Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1031-e1032.
    PubMed    
    
    
    
81. REILLY MP, Bornfeldt KE
    Integrative Multiomics Approaches for Discovery of New Drug Targets for Cardiovascular Disease.
    Circulation. 2021;143:2471-2474.
    PubMed    
    
    
    
82. YEGHIAZARIANS Y, Jneid H, Tietjens JR, Redline S, et al
    Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 21:CIR0000000000000988. doi: 10.1161/CIR.0000000000000988.
    PubMed     Abstract available
    
    
    
83. DAMLUJI AA, van Diepen S, Katz JN, Menon V, et al
    Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 15:CIR0000000000000985. doi: 10.1161/CIR.0000000000000985.
    PubMed     Abstract available
    
    
    
84. ALBERT MA, Carnethon MR, Watson KE
    Disparities in Cardiovascular Medicine.
    Circulation. 2021;143:2319-2320.
    PubMed    
    
    
    
85. LEE H, Yano Y, Cho SMJ, Lee HH, et al
    Associations of Ideal Cardiovascular Health and Its Change During Young Adulthood With Premature Cardiovascular Events: A Nationwide Cohort Study.
    Circulation. 2021 Jun 14. doi: 10.1161/CIRCULATIONAHA.121.054212.
    PubMed    
    
    
    
86. REYNOLDS HR, Picard MH, Spertus JA, Peteiro J, et al
    Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Circulation. 2021 Jun 1. doi: 10.1161/CIRCULATIONAHA.120.046791.
    PubMed     Abstract available
    
    
    May 2021
87. ALTHOUSE AD, Below JE, Claggett BL, Cox NJ, et al
    Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.
    Circulation. 2021 May 25:CIRCULATIONAHA121055393.
    PubMed     Abstract available
    
    
    
88. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    PubMed    
    
    
    
89. CHANG AY, Barry M, Harrington RA
    The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire.
    Circulation. 2021;143:2029-2031.
    PubMed    
    
    
    
90. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    PubMed    
    
    
    
91. GAO R, Wang L, Bei Y, Wu X, et al
    LncRNA CPhar Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2021 May 21. doi: 10.1161/CIRCULATIONAHA.120.050446.
    PubMed     Abstract available
    
    
    
92. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    PubMed     Abstract available
    
    
    
93. LOPES RD, Alexander KP, Hochman JS, Maron DJ, et al
    Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e961-e962.
    PubMed    
    
    
    
94. MORGAN H, Clayton T, Perera D
    Letter by Morgan et al Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e959-e960.
    PubMed    
    
    
    
95. ROHATGI A
    Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.
    Circulation. 2021;143:1946-1948.
    PubMed    
    
    
    
96. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.
    PubMed    
    
    
    
97. DOCHERTY KF, Campbell RT, Brooksbank KJM, Dreisbach JG, et al
    The Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients with Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
    Circulation. 2021 May 13. doi: 10.1161/CIRCULATIONAHA.121.054892.
    PubMed     Abstract available
    
    
    
98. HENDRICKSON BS, Stephens RE, Chang JV, Amburn JM, et al
    Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes: Results of an Algorithm-Guided Screening.
    Circulation. 2021;143:1926-1928.
    PubMed    
    
    
    
99. HAKALA JO, Pahkala K, Juonala M, Salo P, et al
    Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052358.
    PubMed    
    
    
    
100. ZHAO M, Nakada Y, Wei Y, Bian W, et al
     Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
     Circulation. 2021 May 6. doi: 10.1161/CIRCULATIONAHA.120.049497.
     PubMed     Abstract available
     
     
     
101. TAPIA-ORIHUELA RKA, Gutierrez OJ, Del-Carpio Munoz F
     A "Carousel" ECG Confusion.
     Circulation. 2021;143:1824-1827.
     PubMed    
     
     
     April 2021
102. BIRGER M, Kaldjian AS, Roth GA, Moran AE, et al
     Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 - 2016.
     Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.053216.
     PubMed     Abstract available
     
     
     
103. SARTO P, Zorzi A, Merlo L, Vessella T, et al
     Serial Versus Single Cardiovascular Screening of Adolescent Athletes.
     Circulation. 2021;143:1729-1731.
     PubMed    
     
     
     
104. POWELL-WILEY TM, Poirier P, Burke LE, Despres JP, et al
     Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Apr 22:CIR0000000000000973. doi: 10.1161/CIR.0000000000000973.
     PubMed     Abstract available
     
     
     
105. FIGTREE GA, Broadfoot K, Casadei B, Califf R, et al
     A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions.
     Circulation. 2021 Apr 20:CIR0000000000000981. doi: 10.1161/CIR.0000000000000981.
     PubMed     Abstract available
     
     
     
106. KUEHN BM
     Novel Approaches Expand Access to Cardiovascular Preventive Care.
     Circulation. 2021;143:1629-1630.
     PubMed    
     
     
     
107. NEAL B, Wu J
     Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease.
     Circulation. 2021;143:1568-1570.
     PubMed    
     
     
     
108. SCHAUER PR, Nissen SE
     After 70 Years, Metabolic Surgery Has Earned a Cardiovascular Outcome Trial.
     Circulation. 2021;143:1481-1483.
     PubMed    
     
     
     
109. JIA C, Anderson JLC, Gruppen EG, Lei Y, et al
     High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
     Circulation. 2021 Apr 12. doi: 10.1161/CIRCULATIONAHA.120.050808.
     PubMed    
     
     
     
110. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
     Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
     Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
     PubMed     Abstract available
     
     
     
111. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
     Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
     Circulation. 2021;143:e809-e810.
     PubMed    
     
     
     
112. FERRARO R, Arbab-Zadeh A
     Letter by Ferraro and Arbab-Zadeh Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
     Circulation. 2021;143:e805-e806.
     PubMed    
     
     
     
113. SHAH R
     Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
     Circulation. 2021;143:e807-e808.
     PubMed    
     
     
     
114. WENGER NK, Lewis SJ
     Incremental Change versus Disruptive Transformation: COVID-19 and the Cardiovascular Community.
     Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.121.053860.
     PubMed    
     
     
     
115. LANSKY AJ, Kereiakes DJ, Baumbach A, Windecker S, et al
     Novel Supreme(TM) DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
     Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.052482.
     PubMed     Abstract available
     
     
     
116. YACOUB M, Labib D
     Toward Meeting the Challenges of Improving Cardiovascular Health in Egypt.
     Circulation. 2021;143:1341-1342.
     PubMed    
     
     
     
117. SAHOO S, Adamiak M, Mathiyalagan P, Kenneweg F, et al
     Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic.
     Circulation. 2021;143:1426-1449.
     PubMed     Abstract available
     
     
     
118. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
     Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
     Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
     PubMed    
     
     
     March 2021
119. GARGIULO G, Nagler M, Valgimigli M
     Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
     Circulation. 2021;143:e797-e798.
     PubMed    
     
     
     
120. ANGIOLILLO DJ, Bhatt DL, Stone GW
     Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
     Circulation. 2021;143:e795-e796.
     PubMed    
     
     
     
121. PARIKH NI, Gonzalez JM, Anderson CAM, Judd SE, et al
     Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Mar 29:CIR0000000000000961. doi: 10.1161/CIR.0000000000000961.
     PubMed     Abstract available
     
     
     
122. ANAND A, Lee KK, Chapman AR, Ferry AV, et al
     High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial.
     Circulation. 2021 Mar 23. doi: 10.1161/CIRCULATIONAHA.120.052380.
     PubMed     Abstract available
     
     
     
123. 
     Correction to: Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
     Circulation. 2021;143:e792-e793.
     PubMed    
     
     
     
124. DEFILIPPI CR, Mills NL
     Rapid Cardiac Troponin Release After Transient Ischemia: Implications for the Diagnosis of Myocardial Infarction.
     Circulation. 2021;143:1105-1108.
     PubMed    
     
     
     
125. JANKOWSKI J, Floege J, Fliser D, Bohm M, et al
     Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
     Circulation. 2021;143:1157-1172.
     PubMed     Abstract available
     
     
     
126. GREEN JB
     Cardiovascular Consequences of Gestational Diabetes.
     Circulation. 2021;143:988-990.
     PubMed    
     
     
     
127. PELLEGRINI D, Kawakami R, Guagliumi G, Sakamoto A, et al
     Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
     Circulation. 2021;143:1031-1042.
     PubMed     Abstract available
     
     
     
128. BOLLI A, Di Domenico P, Pastorino R, Busby GB, et al
     Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background.
     Circulation. 2021 Mar 8. doi: 10.1161/CIRCULATIONAHA.120.051843.
     PubMed    
     
     
     
129. HENRY TD, Tomey MI, Tamis-Holland JE, Thiele H, et al
     Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Mar 4:CIR0000000000000959. doi: 10.1161/CIR.0000000000000959.
     PubMed     Abstract available
     
     
     
130. PENG AW, Dardari ZA, Blumenthal RS, Dzaye O, et al
     Very High Coronary Artery Calcium (CAC >/= 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2021 Mar 2. doi: 10.1161/CIRCULATIONAHA.120.050545.
     PubMed     Abstract available
     
     
     February 2021
131. PUTOT A, Cottin Y, Zeller M
     Letter by Putot et al Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
     Circulation. 2021;143:e250-e251.
     PubMed    
     
     
     
132. HORIUCHI Y, Wettersten N, Maisel A
     Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
     Circulation. 2021;143:e252-e253.
     PubMed    
     
     
     
133. 
     Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
     Circulation. 2021;143:e744.
     PubMed    
     
     
     
134. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
     Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
     Circulation. 2021;143:837-851.
     PubMed     Abstract available
     
     
     
135. YONG CM, Balasubramanian S, Douglas PS, Agarwal P, et al
     Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences.
     Circulation. 2021;143:755-757.
     PubMed    
     
     
     
136. ELHARRAM M, Hillier E, Hawkins S, Mikami Y, et al
     Regional Heterogeneity in the Coronary Vascular Response in Women With Chest Pain and Nonobstructive Coronary Artery Disease.
     Circulation. 2021;143:764-766.
     PubMed    
     
     
     
137. JI H, Niiranen TJ, Rader F, Henglin M, et al
     Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes.
     Circulation. 2021;143:761-763.
     PubMed    
     
     
     
138. FERRACANE E, Bartoli L, Messori A
     Letter by Ferracane et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
     Circulation. 2021;143:e232-e233.
     PubMed    
     
     
     
139. KESSLER T, Cassese S, Kastrati A
     Letter by Kessler et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
     Circulation. 2021;143:e230-e231.
     PubMed    
     
     
     
140. NAVARESE EP, Khan SU, James S
     Response by Navarese et al to Letters Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
     Circulation. 2021;143:e236-e237.
     PubMed    
     
     
     
141. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
     Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
     Circulation. 2021;143:583-596.
     PubMed     Abstract available
     
     
     
142. ALKHALIL M, Kuzemczak M
     Letter by Alkhalil and Kuzemczak Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
     Circulation. 2021;143:e234-e235.
     PubMed    
     
     
     
143. YBARRA LF, Rinfret S, Brilakis ES, Karmpaliotis D, et al
     Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
     Circulation. 2021;143:479-500.
     PubMed     Abstract available
     
     
     
144. GUNDERSON EP, Sun B, Catov JM, Carnethon M, et al
     Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife: The CARDIA Study.
     Circulation. 2021 Feb 1. doi: 10.1161/CIRCULATIONAHA.120.047320.
     PubMed    
     
     
     January 2021
145. BRAUER M, Casadei B, Harrington RA, Kovacs R, et al
     Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology.
     Circulation. 2021 Jan 28:CIRCULATIONAHA120052666.
     PubMed     Abstract available
     
     
     
146. TOMCSANYI J, Paulik R, Fresz T
     Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
     Circulation. 2021;143:397-400.
     PubMed    
     
     
     
147. OLLITRAULT P, Dolladille C, Chretien B, Milliez P, et al
     Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database.
     Circulation. 2021;143:403-405.
     PubMed    
     
     
     
148. SNIDER JC, Riley LA, Mallory NT, Bersi MR, et al
     Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.
     Circulation. 2021 Jan 21. doi: 10.1161/CIRCULATIONAHA.120.051517.
     PubMed     Abstract available
     
     
     
149. MCEVOY JW
     Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
     Circulation. 2021;143:e20-e21.
     PubMed    
     
     
     
150. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
     Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
     Circulation. 2021;143:e22-e23.
     PubMed    
     
     
     
151. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
     Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
     Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
     PubMed     Abstract available
     
     
     
152. BOIS MC, Boire NA, Layman AJ, Aubry MC, et al
     COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.
     Circulation. 2021;143:230-243.
     PubMed     Abstract available
     
     
     
153. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
     Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
     Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
     PubMed     Abstract available
     
     
     
154. YOUNG JM, Sage JN, Pickering JW, Bannister L, et al
     Next-Day Troponin Tests in Real-World Implementation of Baseline Troponin Rule-Out of Myocardial Infarction Demonstrates Minimal Delayed Troponin Rises.
     Circulation. 2021;143:202-204.
     PubMed    
     
     
     
155. O'FEE K, Panza JA, Brown DL
     Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
     Circulation. 2021;143:205-207.
     PubMed    
     
     
     
156. BHASIN D, Isser HS, Gupta A
     Chest Pain With ST-Segment Elevation in a Young Woman: A Broken Heart?
     Circulation. 2021;143:197-201.
     PubMed    
     
     
     
157. KUEHN BM
     Pandemic Throws Cardiovascular Trials Off Course.
     Circulation. 2021;143:89-90.
     PubMed    
     
     
     
158. RASANEN M, Sultan I, Paech J, Hemanthakumar KA, et al
     VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
     Circulation. 2021;143:65-77.
     PubMed     Abstract available
     
     
     
159. QI Z, Hu L, Zhang J, Yang W, et al
     PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
     Circulation. 2021;143:45-61.
     PubMed     Abstract available
     
     
     December 2020
160. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
     Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
     Circulation. 2020;142:2479-2481.
     PubMed    
     
     
     
161. 
     Correction to: Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
     Circulation. 2020;142:e632.
     PubMed    
     
     
     
162. PAL N, Padala S, Klein K
     Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e501-e502.
     PubMed    
     
     
     
163. BELLEY-COTE EP, Whitlock RP
     Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e503.
     PubMed    
     
     
     
164. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
     Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e504-e505.
     PubMed    
     
     
     
165. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
     Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
     Circulation. 2020;142:2316-2328.
     PubMed     Abstract available
     
     
     
166. DAVE CV, Kim SC, Goldfine AB, Glynn RJ, et al
     Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy.
     Circulation. 2020 Dec 11. doi: 10.1161/CIRCULATIONAHA.120.047965.
     PubMed     Abstract available
     
     
     
167. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
     Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
     Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
     PubMed     Abstract available
     
     
     
168. ARNADOTTIR A, Pedersen S, Hasselbalch RB, Goetze JP, et al
     Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
     Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.046574.
     PubMed     Abstract available
     
     
     
169. 
     Correction to: Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
     Circulation. 2020;142:e449.
     PubMed    
     
     
     
170. MELHEM NJ, Chajadine M, Gomez I, Howangyin KY, et al
     Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine.
     Circulation. 2020 Dec 4. doi: 10.1161/CIRCULATIONAHA.120.050301.
     PubMed     Abstract available
     
     
     
171. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
     Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
     Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
     PubMed     Abstract available
     
     
     
172. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
     Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
     Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
     PubMed     Abstract available
     
     
     
173. FORAKER RE, Benziger CP, DeBarmore BM, Cene CW, et al
     Achieving Optimal Population Cardiovascular Health Requires an Interdisciplinary Team and a Learning Healthcare System: A Scientific Statement From the American Heart Association.
     Circulation. 2020 Dec 3:CIR0000000000000913. doi: 10.1161/CIR.0000000000000913.
     PubMed     Abstract available
     
     
     
174. LIANG T, Gao F, Jiang J, Lu YW, et al
     Loss of Phosphatase and Tensin Homolog Promotes Cardiomyocyte Proliferation and Cardiac Repair After Myocardial Infarction.
     Circulation. 2020;142:2196-2199.
     PubMed    
     
     
     
175. CAPODANNO D, Angiolillo DJ
     Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
     Circulation. 2020;142:2172-2188.
     PubMed     Abstract available
     
     
     November 2020
176. EL KHOUDARY SR, Aggarwal B, Beckie TM, Hodis HN, et al
     Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
     Circulation. 2020 Nov 30:CIR0000000000000912. doi: 10.1161/CIR.0000000000000912.
     PubMed     Abstract available
     
     
     
177. EZEKOWITZ JA, Savu A, Welsh RC, McAlister FA, et al
     Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
     Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.048015.
     PubMed    
     
     
     
178. ARVANITIS M, Qi G, Bhatt DL, Post WS, et al
     A Linear and Non-Linear Mendelian Randomization Analysis of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J Curve Revisited.
     Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.049819.
     PubMed     Abstract available
     
     
     
179. SCHOEPFER H, Nestelberger T, Boeddinghaus J, Twerenbold R, et al
     Effect of a Proposed Modification of the Type 1 and Type 2 Myocardial Infarction Definition on Incidence and Prognosis.
     Circulation. 2020;142:2083-2085.
     PubMed    
     
     
     
180. 
     Correction to: Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: The PEARL Study.
     Circulation. 2020;142:e374.
     PubMed    
     
     
     
181. LEMKES JS
     Coronary Angiography After Cardiac Arrest: A Deep Dive for PEARL.
     Circulation. 2020;142:2013-2015.
     PubMed    
     
     
     
182. KIM HS, Kang J, Hwang D, Han JK, et al
     Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
     Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
     PubMed     Abstract available
     
     
     
183. ROUBILLE F, Tardif JC
     Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
     Circulation. 2020;142:1901-1904.
     PubMed    
     
     
     
184. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
     Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
     Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
     PubMed    
     
     
     
185. RODRIGUEZ F, Solomon N, de Lemos JA, Das SR, et al
     Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.
     Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.052278.
     PubMed     Abstract available
     
     
     
186. HENDREN NS, de Lemos JA, Ayers C, Das SR, et al
     Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
     Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051936.
     PubMed    
     
     
     
187. PACKARD CJ
     Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
     Circulation. 2020;142:e333-e334.
     PubMed    
     
     
     
188. WRIGHT AK, Suarez-Ortegon MF, Read SH, Kontopantelis E, et al
     Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
     Circulation. 2020;142:1925-1936.
     PubMed     Abstract available
     
     
     
189. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
     Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
     Circulation. 2020;142:e335-e336.
     PubMed    
     
     
     
190. FILIPPATOS G, Anker SD, Agarwal R, Pitt B, et al
     Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes.
     Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.051898.
     PubMed     Abstract available
     
     
     
191. KALSTAD AA, Myhre PL, Laake K, Tveit SH, et al
     Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial.
     Circulation. 2020 Nov 15. doi: 10.1161/CIRCULATIONAHA.120.052209.
     PubMed     Abstract available
     
     
     
192. CHERNEY DZI, McGuire DK, Charbonnel B, Cosentino F, et al
     Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.
     Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051901.
     PubMed    
     
     
     
193. MCMURRAY JJV, Wheeler DC, Stefansson BV, Jongs N, et al
     Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.
     Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051675.
     PubMed     Abstract available
     
     
     
194. SIMON JN, Vrellaku B, Monterisi S, Chu SM, et al
     Oxidation of Protein Kinase A Regulatory Subunit PKARIalpha Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release.
     Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.046761.
     PubMed     Abstract available
     
     
     
195. ANKER SD, Butler J, Filippatos G, Khan MS, et al
     Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.
     Circulation. 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
     PubMed     Abstract available
     
     
     
196. ALEXANDER JH, Smith PK
     Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
     Circulation. 2020;142:1797-1798.
     PubMed    
     
     
     
197. ALBERT CL, Carmona-Rubio AE, Weiss AJ, Procop GG, et al
     The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
     Circulation. 2020;142:1865-1870.
     PubMed    
     
     
     
198. PATEL KV, Bahnson JL, Gaussoin SA, Johnson KC, et al
     Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
     Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050941.
     PubMed    
     
     
     
199. VALVERDE I, Singh Y, Sanchez-de-Toledo J, Theocharis P, et al
     Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
     Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050065.
     PubMed     Abstract available
     
     
     
200. HONIGBERG MC, Zekavat SM, Niroula A, Griffin GK, et al
     Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
     Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.051775.
     PubMed     Abstract available
     
     
     
201. KAUFMAN JD, Elkind MSV, Bhatnagar A, Koehler K, et al
     Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
     Circulation. 2020 Nov 5:CIR0000000000000930. doi: 10.1161/CIR.0000000000000930.
     PubMed     Abstract available
     
     
     
202. 
     Correction to: Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
     Circulation. 2020;142:e316.
     PubMed    
     
     
     
203. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
     Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
     Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
     PubMed    
     
     
     October 2020
204. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
     Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
     Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
     PubMed     Abstract available
     
     
     
205. LOWENSTEIN CJ, Solomon SD
     Severe COVID-19 Is a Microvascular Disease.
     Circulation. 2020;142:1609-1611.
     PubMed    
     
     
     
206. NASLUND E, Stenberg E, Hofmann R, Ottosson J, et al
     Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Severe Obesity: A Nationwide Cohort Study.
     Circulation. 2020 Oct 26. doi: 10.1161/CIRCULATIONAHA.120.048585.
     PubMed    
     
     
     
207. WILLIAMS MC, Newby DE, Dey D, Dweck MR, et al
     Response by Williams et al to Letter Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the
     Circulation. 2020;142:e244-e245.
     PubMed    
     
     
     
208. ALFONSO F, Cecconi A, Jimenez-Borreguero J
     Letter by Alfonso et al Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the Heart)".
     Circulation. 2020;142:e242-e243.
     PubMed    
     
     
     
209. SIONTIS GCM, Raber L
     Letter by Siontis and Raber Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)".
     Circulation. 2020;142:e240-e241.
     PubMed    
     
     
     
210. NOLAN JP, Maconochie I, Soar J, Olasveengen TM, et al
     Executive Summary: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed    
     
     
     
211. MORLEY PT, Atkins DL, Finn JC, Maconochie I, et al
     Evidence Evaluation Process and Management of Potential Conflicts of Interest: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed    
     
     
     
212. GREIF R, Bhanji F, Bigham BL, Bray J, et al
     Education, Implementation, and Teams: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
213. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
     Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
214. WYCKOFF MH, Wyllie J, Aziz K, de Almeida MF, et al
     Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
215. OLASVEENGEN TM, Mancini ME, Perkins GD, Avis S, et al
     Adult Basic Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
216. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
     Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
217. MERCHANT RM, Topjian AA, Panchal AR, Cheng A, et al
     Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed    
     
     
     
218. PANCHAL AR, Bartos JA, Cabanas JG, Donnino MW, et al
     Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed    
     
     
     
219. AZIZ K, Lee HC, Escobedo MB, Hoover AV, et al
     Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed    
     
     
     
220. CHENG A, Magid DJ, Auerbach M, Bhanji F, et al
     Part 6: Resuscitation Education Science: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed    
     
     
     
221. TOPJIAN AA, Raymond TT, Atkins D, Chan M, et al
     Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed    
     
     
     
222. MAGID DJ, Aziz K, Cheng A, Hazinski MF, et al
     Part 2: Evidence Evaluation and Guidelines Development: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
223. BERG KM, Cheng A, Panchal AR, Topjian AA, et al
     Part 7: Systems of Care: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
224. MURTHY VL, Reis JP, Pico AR, Kitchen R, et al
     Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.
     Circulation. 2020 Oct 19. doi: 10.1161/CIRCULATIONAHA.120.047689.
     PubMed     Abstract available
     
     
     
225. SHAH P, deFilippi CR, Mullins KE
     Navigating COVID-19 Testing, Special Considerations for the Cardiovascular Clinician.
     Circulation. 2020 Oct 16. doi: 10.1161/CIRCULATIONAHA.120.051183.
     PubMed    
     
     
     
226. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
     Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
     Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
     PubMed    
     
     
     
227. MYHRE PL, Prebensen C, Strand H, Roysland R, et al
     Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19.
     Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050360.
     PubMed     Abstract available
     
     
     
228. 
     Correction to: Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
     Circulation. 2020;142:e234.
     PubMed    
     
     
     
229. 
     Correction to: Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
     Circulation. 2020;142:e236.
     PubMed    
     
     
     
230. 
     Correction to: Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction.
     Circulation. 2020;142:e238.
     PubMed    
     
     
     
231. WANG TJ
     The Evolution of the Cardiovascular Biomarker Study.
     Circulation. 2020;142:1422-1424.
     PubMed    
     
     
     
232. FRANCHI F, Rollini F, Been L, Briceno M, et al
     Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
     Circulation. 2020;142:1500-1502.
     PubMed    
     
     
     
233. MSZAR R, Nasir K, Santos RD
     Coronary Artery Calcification in Familial Hypercholesterolemia: An Opportunity for Risk Assessment and Shared Decision Making With the Power of Zero?
     Circulation. 2020;142:1405-1407.
     PubMed    
     
     
     
234. CACERES BA, Streed CG Jr, Corliss HL, Lloyd-Jones DM, et al
     Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2020 Oct 8:CIR0000000000000914. doi: 10.1161/CIR.0000000000000914.
     PubMed     Abstract available
     
     
     
235. COSENTINO F, Cannon CP, Cherney DZI, Masiukiewicz U, et al
     Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
     Circulation. 2020 Oct 7. doi: 10.1161/CIRCULATIONAHA.120.050255.
     PubMed     Abstract available
     
     
     
236. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
     Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
     Circulation. 2020;142:1320-1329.
     PubMed     Abstract available
     
     
     
237. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
     Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
     Circulation. 2020;142:1399-1401.
     PubMed    
     
     
     
238. RUEL M, Gardner T, Fischbein M, de Lemos J, et al
     Introduction to the 2020 Circulation Cardiovascular Surgery-Themed Issue.
     Circulation. 2020;142:1313-1314.
     PubMed    
     
     
     
239. LYTLE B, Gaudino M
     Fractional Flow Reserve for Coronary Artery Bypass Surgery.
     Circulation. 2020;142:1315-1316.
     PubMed    
     
     
     
240. OHBE H, Goto T, Miyamoto Y, Yasunaga H, et al
     Risk of Cardiovascular Events After Spouse's ICU Admission.
     Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.047873.
     PubMed    
     
     
     
241. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
     Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
     Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
     PubMed     Abstract available
     
     
     September 2020
242. ZUREK M, Johansson E, Palmer M, Albery T, et al
     Neuregulin-1 Induces Cardiac Hypertrophy and Impairs Cardiac Performance in Post-Myocardial Infarction Rats.
     Circulation. 2020;142:1308-1311.
     PubMed    
     
     
     
243. XIA N, Lu Y, Gu M, Li N, et al
     A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection from Myocardial Infarction.
     Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.046789.
     PubMed     Abstract available
     
     
     
244. KERN KB, Radsel P, Jentzer JC, Seder DB, et al
     A Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography for Post-Cardiac Arrest Patients Without ST-Segment Elevation: The PEARL Study.
     Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.049569.
     PubMed     Abstract available
     
     
     
245. RUIZ-VILLALBA A, Romero JP, Hernandez SC, Vilas-Zornoza A, et al
     Single-Cell RNA-seq Analysis Reveals a Crucial Role for Collagen Triple Helix Repeat Containing 1 (CTHRC1) Cardiac Fibroblasts after Myocardial Infarction.
     Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.044557.
     PubMed     Abstract available
     
     
     
246. MALESZEWSKI JJ, Young PM, Ackerman MJ, Halushka MK, et al
     An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.
     Circulation. 2020 Sep 24. doi: 10.1161/CIRCULATIONAHA.120.051362.
     PubMed    
     
     
     
247. CUSHMAN M, Shay CM, Howard VJ, Jimenez MC, et al
     Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.
     Circulation. 2020 Sep 21:CIR0000000000000907. doi: 10.1161/CIR.0000000000000907.
     PubMed     Abstract available
     
     
     
248. PETERS SAE, Colantonio LD, Dai Y, Zhao H, et al
     Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017.
     Circulation. 2020 Sep 21. doi: 10.1161/CIRCULATIONAHA.120.047065.
     PubMed     Abstract available
     
     
     
249. KLASSEN SL, Kwan GF, Bukhman G
     The COVID-19 pandemic: a massive threat for those living with cardiovascular disease among the poorest billion.
     Circulation. 2020 Sep 18. doi: 10.1161/CIRCULATIONAHA.120.047969.
     PubMed    
     
     
     August 2020
250. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
     Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
     Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
     PubMed     Abstract available
     
     
     
251. GAN L, Xie D, Lau WB, Ma XL, et al
     Response by Gan et al to Letter Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mi
     Circulation. 2020;142:e99-e100.
     PubMed    
     
     
     
252. REN C, Chen H, Xie Y
     Letter by Ren et al Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice".
     Circulation. 2020;142:e97-e98.
     PubMed    
     
     
     
253. LI Y, Ding F, Shen Z
     Letter by Li et al Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice".
     Circulation. 2020;142:e95-e96.
     PubMed    
     
     
     
254. 
     Correction to: Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
     Circulation. 2020;142:e71.
     PubMed    
     
     
     June 2020
255. SELVARAJ S, Kelly DP, Margulies KB
     Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
     Circulation. 2020;141:1800-1812.
     PubMed     Abstract available
     
     
     April 2020
256. LI L, Li H, Tien CL, Jain MK, et al
     Kruppel-Like Factor 15 Regulates the Circadian Susceptibility to Ischemia Reperfusion Injury in the Heart.
     Circulation. 2020;141:1427-1429.
     PubMed    
     
     
     
257. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
     Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
     Circulation. 2020;141:1360-1370.
     PubMed     Abstract available
     
     
     
258. KNOTT KD, Seraphim A, Augusto JB, Xue H, et al
     The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence-Based Approach Using Perfusion Mapping.
     Circulation. 2020;141:1282-1291.
     PubMed     Abstract available
     
     
     
259. JIANG M, Knight BP, Verma N
     Conduction Abnormalities and Ischemic Cardiomyopathy in an 84-Year-Old Man.
     Circulation. 2020;141:1268-1270.
     PubMed    
     
     
     
260. CARNETHON MR, Khan SS
     A Feast of Observations About Diet.
     Circulation. 2020;141:1138-1140.
     PubMed    
     
     
     
261. SAXENA A, Garan AR, Kapur NK, O'Neill WW, et al
     Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support.
     Circulation. 2020;141:1184-1197.
     PubMed     Abstract available
     
     
     March 2020
262. SORRENTINO S, Claessen BE, Chandiramani R, Guedeney P, et al
     Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
     Circulation. 2020;141:891-901.
     PubMed     Abstract available
     
     
     February 2020
263. KAZMIRCZAK F, Martin CM, Shenoy C
     Left Ventricular Noncompaction and Cardiogenic Shock.
     Circulation. 2020;141:696-701.
     PubMed    
     
     
     January 2020
264. GAN L, Xie D, Liu J, Lau WB, et al
     Small Extracellular Microvesicles Mediated Pathological Communications between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanisms Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.
     Circulation. 2020 Jan 10. doi: 10.1161/CIRCULATIONAHA.119.042640.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: